Valuation: Procter & Gamble Health Limited

Market Cap 96.57B 1.01B 872M 818M 745M 1.4B 1.42B 9.59B 3.76B 48.38B 3.79B 3.71B 161B P/E 2027 *
26.3x
P/E 2028 * 23.6x
Enterprise Value 96.57B 1.01B 872M 818M 745M 1.4B 1.42B 9.59B 3.76B 48.38B 3.79B 3.71B 161B EV / Sales 2027 *
6.24x
EV / Sales 2028 * 5.54x
Free-Float
47.81%
Yield 2027 *
1.87%
Yield 2028 * 2.03%
1 day-1.96%
1 week-5.40%
Current month-11.82%
1 month-15.07%
3 months+10.04%
6 months+14.94%
Current year+2.04%
1 week 5,808.85
Extreme 5808.85
6,095
1 month 5,808.85
Extreme 5808.85
6,901
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 681
Extreme 681
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 2018-03-31
Director of Finance/CFO - 2025-09-30
Chief Tech/Sci/R&D Officer - 2025-08-31
Director TitleAgeSince
Director/Board Member 57 2018-03-31
Director/Board Member 51 2019-05-31
Chairman 69 2025-03-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.96%-5.40%-7.47%+9.80% 1.03B
-2.49%-3.24%+14.66%+64.56% 48.43B
-0.12%-5.43%+52.28%+115.90% 39.72B
-1.28%-2.21%-8.47%+15.11% 12.25B
-0.33%+1.55%+14.43%+72.12% 11.84B
-0.58%-0.77%+29.90%+141.59% 9.06B
0.00%+1.64%+22.99%+39.94% 7.57B
-0.88%+1.18%+40.97%-13.86% 7.18B
+0.46%+2.19%+13.91%+192.06% 6.84B
+0.63%-2.53%-30.10%+23.84% 5.77B
Average -0.66%-0.13%+14.31%+66.11% 14.97B
Weighted average by Cap. -1.01%-1.24%+23.42%+78.28%

Financials

2027 *2028 *
Net sales 15.47B 162M 140M 131M 119M 224M 228M 1.54B 602M 7.75B 608M 594M 25.79B 17.43B 182M 157M 148M 135M 253M 256M 1.73B 678M 8.73B 685M 670M 29.05B
Net income 3.67B 38.4M 33.15M 31.1M 28.33M 53.26M 54M 365M 143M 1.84B 144M 141M 6.12B 4.09B 42.75M 36.9M 34.62M 31.53M 59.29M 60.11M 406M 159M 2.05B 160M 157M 6.81B
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
26-08-17 5,817.45 -1.96% 690
26-08-14 ₹5,933.70 +0.19% 160
26-08-13 ₹5,922.40 -0.52% 348
26-08-12 ₹5,953.30 -1.28% 910
26-08-11 ₹6,030.35 +1.09% 855
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGHL Stock